Clinical Trial

A Phase 1 Study of Mosliciguat in Healthy, Adult Males

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Status change: Active, Not Recruiting → Completed 2026-06-12
Trial Details
NCT Number NCT07185321
Lead Sponsor Pulmovant, Inc.
Conditions Healthy Volunteer
Enrollment 8 participants
Start Date 2025-06-10
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-07-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-16